← Back to Search

Procedure

Fine needle aspiration (FNA) for Lymphadenopathy

N/A
Waitlist Available
Led By Satish Nagula, MD
Research Sponsored by Stony Brook University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up by three months post-op in the pathology report
Awards & highlights

Study Summary

The purpose of this study is to determine if fine needle aspiration or fine needle biopsy is more efficacious and cost-effective than the other while maintaining diagnostic accuracy in the setting of solid gastrointestinal lesions.

Eligible Conditions
  • Lymphadenopathy
  • Pancreatic Tumors
  • Gastric Tumor
  • Esophageal Tumor
  • Duodenal Tumor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of needle passes needed to obtain a pathologic diagnosis.
Secondary outcome measures
Diagnostic yield, defined as percentage of cases with a diagnostic biopsy sample, between FNA and FNB.
Frequency of adverse side effects.
Visible core specimens obtained and its correlation to obtaining a diagnostic sample.

Trial Design

2Treatment groups
Active Control
Group I: Fine needle aspiration (FNA)Active Control1 Intervention
Endoscopic ultrasound guided needle tissue acquisition: Tissue acquisition using a standard FNA needle
Group II: Fine needle biopsy (FNB)Active Control1 Intervention
Endoscopic ultrasound guided needle tissue acquisition: Tissue acquisition using a new Core needle (Procore; Fine Needle Biopsy).

Find a Location

Who is running the clinical trial?

Columbia UniversityOTHER
1,448 Previous Clinical Trials
2,531,090 Total Patients Enrolled
Weill Medical College of Cornell UniversityOTHER
1,064 Previous Clinical Trials
1,318,786 Total Patients Enrolled
Stony Brook UniversityLead Sponsor
219 Previous Clinical Trials
39,686 Total Patients Enrolled
1 Trials studying Lymphadenopathy
13 Patients Enrolled for Lymphadenopathy
~30 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top